ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
First Trust Nasdaq Pharmaceuticals

First Trust Nasdaq Pharmaceuticals (FTXH)

28.1884
0.06
(0.20%)
Closed July 19 4:00PM
28.1884
0.00
( 0.00% )
Pre Market: 4:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
28.1884
Bid
25.47
Ask
30.87
Volume
-
0.00 Day's Range 0.00
23.85 52 Week Range 28.72
Market Cap
Previous Close
28.1884
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
6,801
Shares Outstanding
-
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About First Trust Nasdaq Pharmaceuticals

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and deposit... The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Headquarters
Boston, Massachusetts, USA
Founded
1970
First Trust Nasdaq Pharmaceuticals is listed in the Mgmt Invt Offices, Open-end sector of the NASDAQ with ticker FTXH. The last closing price for First Trust Nasdaq Pharm... was $28.19. Over the last year, First Trust Nasdaq Pharm... shares have traded in a share price range of $ 23.85 to $ 28.72.

First Trust Nasdaq Pharm... currently has 0 shares outstanding.

FTXH Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.02840.10085227272728.1628.7227.95639128.25013619SP
40.76842.8023340627327.4228.7226.69331156227.37690092SP
122.26848.7515432098825.9228.7225.92680127.07132755SP
261.18844.401481481482728.7225.73605127.31463328SP
521.38845.1805970149326.828.7223.85742226.63086786SP
1562.01847.7126480703126.1728.7223.671160726.43839044SP
2607.566636.692238310920.621828.7216.28967325.73266631SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 11.38
(50.73%)
17.62M
RRRichtech Robotics Inc
$ 1.95
(32.65%)
8.75M
NCPLNetcapital Inc
$ 0.134
(28.85%)
22M
CISOCISO Global Inc
$ 0.7133
(19.88%)
1.63M
MLGOMicroAlgo Inc
$ 3.17
(18.73%)
2.87M
HUBCWHub Cyber Security Ltd
$ 0.0121
(-47.39%)
1.65k
XCURExicure Inc
$ 0.384
(-28.24%)
177.81k
VVOSVivos Therapeutics Inc
$ 2.05
(-16.33%)
1
RYAAYRyanair Holdings PLC
$ 98.37
(-13.95%)
36.18k
SNTGSentage Holdings Inc
$ 2.14
(-13.71%)
20.61k
NCPLNetcapital Inc
$ 0.134
(28.85%)
22M
SERVServe Robotics Inc
$ 11.38
(50.73%)
17.62M
RRRichtech Robotics Inc
$ 1.95
(32.65%)
8.75M
MAXNMaxeon Solar Technologies Ltd
$ 0.2251
(4.41%)
3.02M
SQQQProShares UltraPro Short QQQ
$ 8.23
(-2.72%)
2.95M

Discussion

View Full Feed
Jaxxm Jaxxm 42 seconds ago
MAXN has 545 Million outstanding shares, increases every week. Moved to TKLF 42 million os posted net profit
MAXN TKLF
JLPTNG JLPTNG 1 minute ago
****FOR NEWBIES****


$LWLG issuing more shares - Huge dilution and Lebbys whores liquidating - this company has zero value, no sales, no revenue, HUGE losses - they only way they are here is more dilution - pathetic


3 'Ds" to Lebbys strategy
LWLG
oystersnbeer oystersnbeer 1 minute ago
https://www.youtube.com/watch?v=tegw25qqbAs

https://www.youtube.com/watch?v=KMWsYJxCK4I

https://qph.cf2.quoracdn.net/main-qimg-a96e7c0550efe46d396f0e8f8d916027
Batman412 Batman412 2 minutes ago
I’ll be happy if it sees 0012 again
TONR
LVerstee LVerstee 2 minutes ago
Then there should be zero delay. That money should be in today and we all should be seeing our funds.
ITUP
CanItBThisEZ2Make CanItBThisEZ2Make 2 minutes ago
BEST SELLERS RANK (BSR) IS 662 15 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value De
SRMX
timberwolf7 timberwolf7 2 minutes ago
Tomorrow morning is going to be one of those 'binary' events in the

baby bio tech world isn't it.
JAGX
HGilS HGilS 4 minutes ago
To all longs - have a wonderful week :-)
Getting closer to the next CC.
Chances of having a PR are getting higher on a daily basis. 5.08% to get a PR
ELTP
Monksdream Monksdream 4 minutes ago
Whoops, I did it, again
HEPA
Midwestrader Midwestrader 5 minutes ago
ROFLMAO!!! Holding short positions?!?!?! This POS CON JOB trades at 0.0001 you dip,how much lower can it go IF anyone was shorting?? Wow...your knowledge of how stock trading works is at a kindergarten level. Anyone spending ten seconds on OTC Markets can see the REAL shorting of any stock which mu
INND
shotsky shotsky 5 minutes ago
Vik has none, Jake was paid off with shares.
NSAV
Awl416 Awl416 5 minutes ago
STRATA Skin Sciences Announces Approval of XTRAC Momentum™ 1.0 Device in Japan
SSKN
jedijazz jedijazz 5 minutes ago
$CYCA: Cytta Corp (CYCA) offers CyttaCOMMS incident management system with real-time video & audio streams for ongoing, relevant, actionable intelligence for First Responders. CyttaCARES is a game-changer in ensuring the safety of children in educational institutions and beyond. www.cytta.com #OTCQB
CYCA
Awl416 Awl416 5 minutes ago
Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement
HEPA
jedijazz jedijazz 5 minutes ago
$CYCA: Cytta Corp (CYCA) offers CyttaCOMMS incident management system with real-time video & audio streams for ongoing, relevant, actionable intelligence for First Responders. CyttaCARES is a game-changer in ensuring the safety of children in educational institutions and beyond. www.cytta.com #OTCQB
CYCA
Minddoc7 Minddoc7 6 minutes ago
COINTELEGRAPH Article: Arkham transfers $487M ARKMs to Coinbase Prime for tax compliance.
by Amaka Nwaokocha July 21, 2024

" The transfer to Coinbase Prime is a strategic step for Arkham, aligning with the company’s commitment to regulatory adherence and robust security measur
COIN
TurboDiesel06 TurboDiesel06 7 minutes ago
https://x.com/TPSAsiaPacific/status/1815354855218909682?t=zV_3EJ9wnRNJr15Xb2bG_A&s=19
ICNM
WooptdooU WooptdooU 7 minutes ago
Notforlong(s) lebby and the marcinobody guy TOOK an ENTIRE quarter of cash burn from a company with zero revenue because the in the pocket bod (mostly the SHIP JUMPER) allowed it. Who does that?

They all sold and made millions off of fools like me and all the helplessly hopeful penny
LWLG
hedge_fun hedge_fun 8 minutes ago
Isn’t the issue the divers are needed……

to assist the device in the scan?

5 years ago this thing was said to be autonomous and more efficient than anything on the market.

https://investorshub.advfn.com/uimage/uploads/2020/2/23/dkqbrTinkerbell_2.0.PNG
SFRX
Mufaso Mufaso 8 minutes ago
IMO Oral obesity drugs most likely to succeed based on data so far are LLY’s Orforglipron, VKTX’s VK2735 and Roche’s CT-996.

Orforglipron which is the most advanced, has decent weight loss plus a tolerability profile “consistent with the class” . Results from orforglipron's phase 3 w
LLY VKTX
green maschine green maschine 8 minutes ago
Good morning HOLO. This looks good for a bounce.
HOLO
FDApproved FDApproved 8 minutes ago
Pluri’s CDMO to Manufacture Kadimastem’s Cell Therapy Candidates

https://www.contractpharma.com/contents/view_breaking-news/2024-07-18/pluris-cdmo-to-manufacture-kadimastems-cell-therapy-candidates/
CDMO

Your Recent History